Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis.
Study Goal
The researchers aimed to determine the effect of resistance training (RT) on walking ability in persons with peripheral artery disease (PAD).
Results Summary
RT significantly improved walking ability, including claudication onset and total walking distance on treadmills and flat ground, with high-intensity training yielding the greatest improvements. The study supports including high-intensity lower body RT in PAD treatment.
Population
Persons with peripheral artery disease (mean age 67.1±3.8 years).
Effective Dosage
Training ranged from low to high intensity, 2-7 times per week.
Duration
17±7 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Resistance training (RT) | increase | walking ability | persons with peripheral artery disease | - | improves | #1 |
Resistance training (RT) | increase | constant load treadmill claudication onset (COD) | patients with peripheral artery disease | SMD 0.66 [0.40, 0.93] | significantly improved | #2 |
Resistance training (RT) | increase | total walking distance (WD) | patients with peripheral artery disease | SMD 0.51 [0.23, 0.79] | significantly improved | #3 |
Resistance training (RT) | increase | progressive treadmill COD | patients with peripheral artery disease | SMD 0.56 [0.00, 1.13] | improved | #4 |
Resistance training (RT) | increase | total WD | patients with peripheral artery disease | SMD 0.45 [0.08, 0.83] | improved | #5 |
Resistance training (RT) | increase | 6-MWT COD | patients with peripheral artery disease | MD 82.23 m [40.91, 123.54] | improved | #6 |
high-intensity training | increase | walking ability | patients with peripheral artery disease | - | yielding the greatest improvement | #7 |
Resistance training (RT) | increase | treadmill and flat ground walking ability | persons with peripheral artery disease | - | clinically improved | #8 |
Higher intensity training | increase | walking ability | persons with peripheral artery disease | - | was associated with better outcomes | #9 |
OBJECTIVE: Resistance training (RT) improves walking ability in persons with peripheral artery disease. We conducted a meta-analysis of randomised controlled trials (RCTs) investigating the effect of RT on peripheral artery disease (as measured by walking ability). DESIGN: We included RCTs that investigated the effect of RT on treadmill and/or 6 min walk (6-MWT) distances. RT intensity was assessed according to the American College of Sports Medicine guidelines by 1 repetition maximum or rating of perceived exertion. Standardised mean (SMD) and mean differences (MD) were calculated using a random-effects inverse variance model. Heterogeneity and bias were assessed using RevMan V.5.3. Meta-regression and meta-analysis of variance were performed as moderator analyses. DATA SOURCES: Databases (Medline, Embase, Web of Science, Cinahl and Google Scholar) were searched until July 2018. RESULTS: Fifteen trials isolated RT; 7 trials compared RT with aerobic exercise. We analysed 826 patients (n=363 completing RT), with a mean age of 67.1±3.8 years. Training ranged from low-high intensity, 2-7 times per week for 17±7 weeks, with a mix of upper, lower or whole body training. Overall RT significantly improved constant load treadmill claudication onset (COD) (SMD 0.66 [0.40, 0.93], p<0.00001) and total walking distance (WD) (SMD 0.51 [0.23, 0.79], p=0.0003), progressive treadmill COD (SMD 0.56 [0.00, 1.13], p=0.05) and total WD (SMD 0.45 [0.08, 0.83], p=0.02), and 6-MWT COD (MD 82.23 m [40.91, 123.54], p<0.0001). Intensity played a role in improvement, with high-intensity training yielding the greatest improvement (p=0.02). CONCLUSIONS: RT clinically improved treadmill and flat ground walking ability in persons with peripheral artery disease. Higher intensity training was associated with better outcomes. Our study makes a case for clinicians to include high-intensity lower body RT in the treatment of peripheral artery disease. TRIAL REGISTRATION NUMBER: CRD42017081184.